NCT02708056View on ClinicalTrials.gov

Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Brain Cancer
Interventions
DRUG

Sugammadex

All Listed Sponsors
lead

Baskent University

OTHER

NCT02708056 - Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants | Biotech Hunter | Biotech Hunter